• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bradycardia (1751); Stroke/CVA (1770); Hematoma (1884); Myocardial Infarction (1969); Ischemia Stroke (4418); Restenosis (4576)
Event Date 05/02/2021
Event Type  Injury  
Manufacturer Narrative
Age: average age.Sex: majority gender.Event date: date of article publication could gender impact on immediate and long-term carotid artery stenting outcome? insight from an italian single center experience annals of vascular surgery (2021) 76:342-350 10.1016/j.Avsg.2021.04.014.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A retrospective monocentric study was conducted on 568 patients (366 males and 202 females).Carotid stenting was carried out using exclusively self-expanding stents.Cerebral protection devices were used in all cases per operators¿ experience.Protégé self-expanding stent were implanted, and spider fx and mo.Ma embolic protection devices were the medtronic devices used in the study.Procedures were preferentially carried out percutaneously via puncture of the common femoral artery, but brachial access or direct surgical approach to cca were adopted when needed, according to aortic arch and target carotid anatomies.Pre- and post-dilatation were not routinely performed.Atropine (0.5¿1 mg) was given intravenously to most patients just before the post-stenting dilation phase to reduce bradycardia and hypotension potentially associated with carotid dilation.All patients underwent an angiographic examination of the culprit carotid lesion in 2 projections and an angiographic examination of the intracranial circulation in anteroposterior and/or lateral projections.The same angiographic imaging was performed at the end of the procedure to determine whether there was any variation in the intracranial blood flow.During the peri-procedural time (in-hospital stay), there was one death for acute lung failure, no episodes of major stroke and one non-fatal acute myocardial infarction (ami).16 minor stroke and 11 tia were registered.In terms of minor complications, 18 episodes of bradycardia, 9 vascular access complications were registered, defining a fundamentally comparable scenario between the two populations examined.One month follow-up with dus showed good technical results without any episode of external carotid occlusion.On long term results (medium follow-up 57 months) we recorded 32 stroke (8 major strokes, 24 minor strokes) episodes, 24 acute myocardial infarction (ami), 13 restenosis and 223 deaths with a slight majority of women dying on the long term.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE RX CAROTID STENT SYSTEM
Type of Device
STENT, CAROTID
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key12967300
MDR Text Key286431159
Report Number2183870-2021-00450
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P060001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/01/2021
Initial Date FDA Received12/09/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient SexMale
-
-